The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients-Reference-Cited by-同舟云学术

The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients

Author:

Zhuo Minglei¹²¹,Chen Hanxiao¹²¹,Zhang Tianzhuo³,Yang Xue¹²,Zhong Jia¹²,Wang Yuyan¹²,An Tongtong¹²,Wu Meina¹²,Wang Ziping¹²,Huang Jing³,Zhao Jun¹²

Affiliation:

1. Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing, China

2. Department of Thoracic Medical Oncology, Peking University Cancer Hospital and Institute, Beijing 100142, China

3. Department of Immunology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference49 articles.

2. The incidences and mortalities of major cancers in China, 2010;Chen;Chin J Cancer,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献